STARGARDT MACULAR DYSTROPHY
Clinical trials for STARGARDT MACULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new STARGARDT MACULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for STARGARDT MACULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to sharpen vision tests for those with severe sight loss
Knowledge-focused Recruiting nowThis study is for people with retinal diseases like retinitis pigmentosa and Stargardt disease who have severe vision loss (20/200 to hand motion). Researchers want to see if standard vision tests work well for these patients and how reliable they are. The goal is to develop bett…
Matched conditions: STARGARDT MACULAR DYSTROPHY
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 02, 2026 06:34 UTC
-
New study tracks vision loss in stargardt disease – no treatment, just observation
Knowledge-focused Recruiting nowThis study watches how Stargardt disease and similar inherited eye conditions get worse over time. Researchers will follow children (ages 6+) and adults for up to 2 years, doing regular eye exams and imaging. No new treatments are tested—the goal is to better understand how these…
Matched conditions: STARGARDT MACULAR DYSTROPHY
Sponsor: Astellas Pharma Global Development, Inc. • Aim: Knowledge-focused
Last updated Apr 23, 2026 12:45 UTC